Decompensation of Cirrhosis and Iron Metabolism
Decompensation of Cirrhosis and Iron Metabolism
Iron is a crucial metal whose metabolism is tightly regulated. Iron deficiency or iron
 overload are both deleterious at the cellular, organic and systemic levels. In line with the
 major role of the liver in iron homeostasis, links between iron metabolism and acute on
 chronic liver failure have been highlighted. Nevertheless, due to the difficulty of
 accurately assessing iron metabolism in this situation, therapeutic intervention on iron
 metabolism in this setting is currently not codified.

 A better understanding of these mechanisms is therefore essential, in particular by
 characterizing the impact of exposure to non-transferrin-bound iron in acute on chronic liver
 failure on short-term mortality.

 Overall, a better understanding of the physiopathological mechanisms of iron should allow to
 optimize the martial balance in this condition and also improve therapeutic approaches.
Inclusion Criteria:

 -  Age ≥ 18 years old.

 -  Diagnosis of cirrhosis, previously known or not, of any etiology, histologically
 proven or not.

 -  Hospitalization for acute on chronic liver failure:

 -  Ascites decompensation.

 -  Or spontaneous infection of the ascites fluid (defined as PNN > 250/mm3 of ascites).

 -  Or digestive hemorrhage related to portal hypertension (digestive fibroscopy showing
 active bleeding or stigmas of recent bleeding from esophageal and/or gastric varices).

 -  Or hepatic encephalopathy (clinically defined +/- increase in ammonia and/or by
 electroencephalogram and classified in stages according to West-Haven).

 -  Or hepato-renal syndrome (HRS-AKI criteria, EASL 2018).

 -  Or bacterial infection (defined by a bacteremia identified by at least one blood
 culture and/or an infectious site authenticated on imaging).

 -  Or Acute Alcoholic Hepatitis (histologically proven or not).

 -  Non-opposition of the patient, relative or legal representative.

 Exclusion Criteria:

 -  Treatment with oral or intravenous iron in the month prior to hospitalization.

 -  Implementation of a TIPS in the month prior to admission.

 -  Presence of hepatocellular carcinoma with an expected survival < 3 months or any other
 progressive cancer.

 -  Adult person subject to legal protection (safeguard of justice, curatorship,
 guardianship), person deprived of liberty.